India Vitamin B1 Market to grow at a CAGR of 11.05% during the forecast period
Growing
awareness pertaining to health among the population is expected to drive the
growth of India vitamin B1 market growth in the forecast period, 2026-2030.
According to TechSci Research report, “India
Vitamin B1 Market -Industry Size, Share, Trends, Competition Forecast
& Opportunities, 2030”, The India Vitamin B1 Market was valued
at USD 243.43 Million in 2024 and is expected to reach USD 453.97 Million by
2030, growing with a CAGR of 11.05% in the forecast period.
The
India Vitamin B1 market has been evolving rapidly, shaped by increasing
awareness of nutritional health and the growing emphasis on preventive care.
With lifestyle-related disorders on the rise, more individuals are turning to
dietary supplements to fill nutritional gaps. Vitamin B1, or thiamine, plays a
vital role in energy production and nerve function, making it a sought-after
ingredient in both pharmaceutical and nutraceutical formulations. The shift
toward processed and convenience foods, while increasing the risk of
micronutrient deficiencies, has also driven interest in fortified food
products. As consumers become more educated about the consequences of vitamin
deficiencies, particularly among children and the elderly, demand for targeted
supplements continues to grow.
Browse over XX market data Figures
spread through XX Pages and an in-depth TOC on "India Vitamin B1 Market”
The market also reflects a growing trend of
innovation, with manufacturers introducing thiamine in diverse delivery forms
such as capsules, syrups, dissolvable strips, and fortified beverages. This
shift aims to cater to varied consumer preferences across age groups and health
needs. For children, flavored syrups and chewables make supplementation easier,
while adults and the elderly often prefer capsules or tablets for convenience.
These innovations enhance user compliance and make Vitamin B1 supplementation
more appealing.
Contract manufacturing is playing a significant role
in boosting production capacity and improving product accessibility. It enables
smaller and mid-sized brands to launch Vitamin B1 products without heavy
investment in infrastructure. These partnerships help meet increasing demand
while maintaining product quality and regulatory compliance. Urban centers
benefit from better retail penetration, while contract manufacturers also
support rural outreach by producing cost-effective formulations.
Government-led nutrition programs and broader public
health initiatives are also supporting the inclusion of thiamine. Fortification
of staple foods and mid-day meal schemes ensures that vulnerable populations
receive essential nutrients, even without direct supplementation. These efforts
are gradually increasing baseline thiamine intake across diverse demographics.
Despite existing challenges like low awareness in
remote areas, price sensitivity, and limited health literacy, the market
outlook remains optimistic. The expanding middle class is becoming more
health-conscious, supported by improved access to healthcare, digital retail
platforms, and nutritional education. As wellness becomes a higher priority
across socio-economic segments, the demand for thiamine-based products is
expected to grow steadily, reinforcing the long-term potential of the India
Vitamin B1 market.
The India Vitamin B1 Market is segmented into product
type, source, form, dosage strength, distribution channel, application, end
user, regional distribution, and company.
Based on form, tablets are the dominant form in the
India Vitamin B1 market. Their popularity stems from ease of consumption,
longer shelf life, and cost-effectiveness in large-scale production. Tablets
are widely accepted among consumers due to their familiarity and convenience,
especially for daily supplementation. They are also easier to distribute and
store, making them ideal for both retail and government health programs.
Compared to capsules and injectable solutions, tablets offer a more economical
option, appealing to price-sensitive markets across urban and rural areas.
Capsules, while effective and sometimes preferred for quicker absorption, are
more commonly used in premium health products and specific therapeutic
segments. Injectable solutions, though potent and used in clinical settings for
severe deficiencies or emergency care, are limited to hospitals and
prescriptions. Tablets strike a balance between affordability, accessibility,
and consumer preference, making them the leading choice in the Vitamin B1 product
landscape in India.
Based on dosage strength, the 100mg dosage is the most
dominant in the India Vitamin B1 market. It is widely prescribed and commonly
used for both therapeutic and preventive purposes. This dosage offers a
balanced strength suitable for treating mild to moderate thiamine deficiencies
without the risk of over-supplementation. It is often included in multivitamin
formulations and over-the-counter supplements, making it accessible to a broad
consumer base. Compared to 50mg, it provides greater efficacy, while 250mg is
typically reserved for severe clinical cases and less common in general retail.
The 100mg format is favored for its versatility and broad applicability across
age groups.
Based on end user, the adult segment is dominant in
the India Vitamin B1 market. This is driven by a higher prevalence of
lifestyle-related health issues such as fatigue, stress, and poor diet among
working-age individuals, which increases the demand for vitamin supplements.
Adults are more likely to self-administer over-the-counter vitamins or receive
prescriptions for thiamine in cases of deficiency. They also form the primary
target group for preventive healthcare and wellness products. In contrast, the
pediatric segment, while important, relies more on parental awareness and
healthcare guidance, leading to relatively lower consumption levels. As a
result, adult consumers account for the majority of market demand.
Based on region, South India is the fastest-growing
region in the India Vitamin B1 market due to its strong healthcare
infrastructure, high literacy rates, and growing awareness of preventive
health. Urban centers like Bengaluru, Chennai, and Hyderabad have a large base of
health-conscious consumers who actively seek nutritional supplements. The
region also has a significant presence of pharmaceutical and nutraceutical
manufacturers, supporting local production and distribution. Rising disposable
incomes and a culturally ingrained focus on wellness and balanced diets
contribute to increased demand. E-commerce adoption and better access to health
products across both urban and semi-urban areas further accelerate market
growth in South India.
Major companies operating in India
Vitamin B1 Market are:
·
Meteoric Biopharmaceuticals Pvt. Ltd.
·
Alpspure Lifesciences Private Limited
·
GlaxoSmithKline Pharmaceuticals Ltd
·
DSM Nutritional Products India Pvt. Ltd
·
Crystal Pharma Ltd
·
Qualitek Pharma Pvt. Ltd.
·
Biophore India Pharmaceuticals Private Limited
·
Prachi Pharmaceuticals Pvt. Ltd.
·
Helichem Laboratories Pvt Ltd
·
Otto Chemie Pvt Ltd.
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The Indian Vitamin B1 market has experienced
consistent growth driven by a combination of rising nutritional awareness,
urban lifestyle changes, and an increasing focus on preventive healthcare. As
more consumers recognize the importance of micronutrients in daily wellness,
demand for Vitamin B1 has expanded across both urban and rural areas. The
market is also benefiting from the growing popularity of dietary supplements
and fortified foods. Wider product availability, improved distribution
networks, and innovative formulations have made thiamine more accessible. With
a health-focused mindset gaining momentum among various age groups, the market
is expected to maintain steady upward growth in the coming years” said Mr.
Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“India Vitamin B1 Market By Product Type (Thiamine Nitrate
Type, Thiamine Hydrochloride Type, Others), By Source (In-house v/s Contract
Manufacturing Organizations), By Form (Tablet, Capsule, Injectable Solution),
By Dosage Strength (50mg, 100mg, 250mg), By Distribution Channel (Online v/s
Offline), By Application (Beriberi, Wernicke's Encephalopathy Syndrome,
Delirium, Others), By End User (Adult v/s Pediatric), By Company, Region,
Forecast & Opportunities, 2020-2030F”, has
evaluated the future growth potential of India Vitamin B1 Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in India Vitamin B1 Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com